Cambridge, Mass.-based InVivo Therapeutics has named Steven McAllister as its interim CFO as of Dec. 31.
The Latest
After meeting recently, a U.S. Food and Drug Administration committee agreed spinal sphere devices should be classified as Class 3 devices, which require premarket approval, according to a Medscape report.
Patients that underwent surgery for discogenic back pain showed greater improvement at one year than those that underwent non-surgical treatment, according to a study published in The Spine Journal.
Gastonia, N.C.-based CaroMont Health announced the addition of Steven K. Gudeman, MD, to the medical staff at CaroMont Neurosurgery in Gastonia.
Troy (Ala.) Regional Medical Center has added Robert Liljeberg, MD, to its medical staff, according to a Troy Messenger report.
The Orthopedic Institute of Pennsylvania in Camp Hill announced plans to merge with Appalachian Orthopedic Center in Carlisle, Pa., according to report by The Sentinel.
The Medical Group Management Association Legislative and Executive Advocacy Response Network recently launched the ACA Insurance Exchange Implementation Report, which found that 14.4 percent of physicians do not plan participating in new health insurance exchange products, while another 56.4 percent…
The American Academy of Orthopaedic Surgeons supports the recent legislative efforts to repeal the sustainable growth rate.
The American Association of Neurological Surgeons and Congress of Neurological Surgeons co-signed a letter with five other organizations in support of the Traumatic Brain Injury Reauthorization Act of 2013.
An article recently published in The Spine Journal found that survival rate for primary spinal fusion in adult scoliosis patients was 89.8 percent at one year postoperatively.